The selection process evaluated cost-effectiveness and flexiblity of solutions that add value to the patient monitoring landscape.

CleveMed, Cleveland, OH – Nov 3, 2015 – CleveMed, a leading provider of cloud-based home sleep apnea testing (HSAT) solutions was named today by Healthcare Tech Outlook among the 10 most promising patient monitoring solution providers.  The selection process looked at vendor’s capability to fulfill the need for cost-effective and flexible solutions that add value to the patient monitoring landscape. The positioning is based on the evaluation of CleveMed’s innovative solutions that streamlines the physician’s practice workflow, provides data management, and offers access to sleep medicine specialty care for patients as well as hospital departments.

The annual list of companies is selected by a panel of experts and members of Healthcare Tech Outlook’s editorial board to recognize and promote technology entrepreneurship. “CleveMed has continued to provide innovative solutions in Patient Monitoring arena for quite some time thereby reinventing the current landscape. We are happy to showcase them this year due to their excellence in delivering best-of-breed technology-driven solutions,” said Alex D’souza, Managing Editor, Healthcare Tech Outlook. “CleveMed solutions continued to break new ground within the past year, benefiting its customers around the globe, and we’re excited to have them featured on our top companies list.”

“This award is recognition of our team’s hard work, product quality, and corporate strategy.  Our cloud-based solutions do not only offer ways to test patients at home conveniently and less expensively, but we do that in a manner that retains the involvement of sleep specialists. Whether it is our own network of sleep technologists and doctors or local sleep centers, the availability of sleep specialty oversight offers un-paralleled clinical care that is much-needed as sleep apnea care transitions from the hospital to the home,” said Hani Kayyali, CleveMed president.

Obstructive sleep apnea (OSA), the most prevalent form of sleep apnea, is a repeated interruption of normal breathing during sleep due to a collapse of the upper airway. It is estimated to impact as many people as asthma and diabetes; yet, up to 80 percent of the population with the disease remain undiagnosed and untreated. Moreover, OSA leads to serious health and economic consequences. Numerous studies link OSA to major chronic diseases such as stroke, heart failure, diabetes, obesity, hypertension and increased odds of serious car crash injuries.

HealthCare Tech Outlook constantly endeavors to identify “The Best” in a variety of areas important to healthcare. Through nominations and consultations with industry leaders, our editors choose the best in different domains. Patient Monitoring Solution Providers is an annual listing of 10 Most Promising Patient Monitoring Solution Providers in the U.S.

CleveMed is a fast growing company with a wide range of sleep testing services and cloud based technologies that allow sleep disorders to be monitored in the home, including Sapphire PSG, SleepScout, SleepView®, SleepViewSM Web-portal, and SleepView Direct. CleveMed’s goal is to expand the reach of sleep services with testing that speeds diagnosis and treatment for providers, reduces healthcare costs for payers, and most importantly improves patients’ experience. For more information, please visit www.CleveMed.com (Follow us on twitter, youtube, LinkedIn, and facebook).  SleepView is a registered trademark and a service mark, and Sapphire PSG and SleepScout are trademarks of Cleveland Medical Devices Inc. of Cleveland, OH.

PDF Version >>